We’re a small charity that makes a big difference to children with cancer through pioneering research.
The Children’s Cancer Research Fund is a volunteer-led charity that provides funding for early-stage children’s cancer research to get new ideas off the ground. Without our help many research projects would never get underway, meaning critical breakthroughs in childhood cancer research being left undiscovered.
50 years ago, three quarters of children diagnosed with cancer died. Today, more than 8 in 10 survive – thanks to research. But many childhood cancers still have a poor outlook and today’s treatments are harsh, unpleasant, and uncertain. Research is the only thing that will change that outlook.
Over the past 30+ years, we have funded a total of 28 research projects at a cost of almost £3 million covering all kinds of childhood cancers.
Friends of is a place where children, families, and friends can come together for the benefit of all children with cancer. You can share your child’s story, fundraise directly in their honour, and help fund new research for the good of all.
We focus on kick-starting new ideas to change the outlook for children with cancer.
There are load of ways you can get involved and be the difference for children with cancer.
We’re proud to work with other charities and organisations. Together we can make the most difference.
Together, we can give all children with cancer a brighter future. Become a supporter and help us.
In 2021, we were delighted to collaborate with Neuroblastoma UK on a research grant of £469,093, awarded to an international team of leading clinician-scientists to
We are delighted to open a research grant call for 2025. Thanks to the support of our fantastic donors and supporters, we are now able
📣 Calling all businesses and community groups across Altrincham! 📣 This September, we’re turning up the energy across Altrincham in support of Active Altrincham month
© 2025 Children’s Cancer Research Fund | Charity No. 1046278 | Website by ATTAIN.
John Hickman was the ICI Professor of Molecular Pharmacology at the University of Manchester. After a postdoctoral fellowship at the Institute of Cancer Research London, he held University posts in Liverpool, Birmingham and Manchester and as a visiting scientist at Yale University. He was the lead pharmacologist for the discovery of the drug Temozolomide, used to treat brain cancers. Professor Hickman moved to Paris in 2000 to direct cancer drug discovery at Servier. He retired in 2010 and then coordinated a European Union Innovative Medicines Initiative (IMI) consortium. From 2016 – 2022, John was Chair of the Friends of Rosie SAB. In 2022, he hosted the first of a series of international childhood cancer research symposiums for Friends of Rosie.
Katrina has specialised in the field of occupational personal injury for over 35 years and has worked exclusively for the victims of asbestos related diseases for the last 20 years. Katrina is an APIL Accredited Occupational Disease and Asbestos Disease Specialist and Senior Litigator and has Law Society Personal Injury Accreditation.
Carla has over 20 years’ experience specialising in strategic communications, engagement and marketing across the public and private sector, including the BBC, Manchester Metropolitan University and Muse Developments. She is currently Executive Director of Corporate Affairs and Marketing for The Growth Company, an award-winning social enterprise that enables growth, creates jobs and improves lives.
